Mark Massaro
Stock Analyst at BTIG
(3.27)
# 1,073
Out of 4,479 analysts
93
Total ratings
43.64%
Success rate
2.18%
Average return
Main Sectors:
28 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNA Ginkgo Bioworks Holdings | Maintains: Sell | $0.5 → $0.2 | $0.35 | -42.28% | 5 | Jun 26, 2024 | |
| WGS GeneDx Holdings | Maintains: Buy | $19 → $35 | $27.76 | +26.08% | 3 | Jun 26, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $80 → $70 | $43.17 | +62.15% | 11 | Jun 26, 2024 | |
| BNGO Bionano Genomics | Maintains: Buy | $3 → $2 | $0.57 | +250.75% | 7 | May 16, 2024 | |
| AKYA Akoya Biosciences | Maintains: Buy | $9 → $6 | $2.18 | +175.23% | 2 | May 14, 2024 | |
| NTRA Natera | Maintains: Buy | $100 → $125 | $110.70 | +12.92% | 7 | May 13, 2024 | |
| NEO NeoGenomics | Maintains: Buy | $23 → $21 | $13.73 | +52.95% | 4 | May 2, 2024 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $6 → $5 | $3.37 | +48.37% | 2 | Apr 4, 2024 | |
| MXCT MaxCyte | Maintains: Buy | $10 → $8 | $3.72 | +115.05% | 3 | Mar 13, 2024 | |
| TKNO Alpha Teknova | Downgrades: Neutral | n/a | $1.23 | - | 1 | Mar 12, 2024 | |
| MDXH MDxHealth | Maintains: Buy | $7 → $8 | $2.27 | +252.42% | 8 | Mar 7, 2024 | |
| SOPH SOPHiA GENETICS | Maintains: Buy | $7 → $8 | $4.59 | +74.29% | 2 | Mar 6, 2024 | |
| TLIS Talis Biomedical | Maintains: Sell | $0.35 → $5 | $8.50 | -41.18% | 3 | Aug 16, 2023 | |
| CSTL Castle Biosciences | Maintains: Buy | $38 → $30 | $21.26 | +41.11% | 2 | Jun 15, 2023 | |
| RNLX Renalytix | Maintains: Buy | $4 → $3.5 | $0.25 | +1,283.95% | 3 | Apr 3, 2023 | |
| XGN Exagen | Maintains: Buy | $6 → $5 | $1.78 | +180.90% | 3 | Mar 22, 2023 | |
| CDNA CareDx | Maintains: Buy | $28 → $25 | $14.90 | +67.79% | 2 | Feb 28, 2023 | |
| GH Guardant Health | Maintains: Buy | $60 → $50 | $28.87 | +73.19% | 1 | Feb 24, 2023 | |
| CERS Cerus | Downgrades: Neutral | n/a | $1.70 | - | 1 | Jan 20, 2023 | |
| LUCD Lucid Diagnostics | Maintains: Buy | $5 → $3.5 | $0.78 | +348.72% | 2 | Nov 18, 2022 | |
| TTOO T2 Biosystems | Downgrades: Neutral | n/a | $5.08 | - | 2 | Jul 7, 2022 | |
| OCX OncoCyte | Initiates: Buy | n/a | $2.96 | - | 1 | Nov 30, 2020 | |
| AXDX Accelerate Diagnostics | Initiates: Neutral | n/a | $1.15 | - | 1 | Oct 8, 2020 | |
| LH Labcorp Holdings | Maintains: Hold | n/a | $202.73 | - | 4 | Dec 3, 2018 | |
| DGX Quest Diagnostics | Maintains: Buy | n/a | $136.64 | - | 3 | Oct 24, 2018 | |
| HOLX Hologic | Maintains: Hold | n/a | $73.53 | - | 3 | Sep 27, 2018 | |
| QDEL QuidelOrtho | Maintains: Buy | n/a | $31.36 | - | 4 | Sep 10, 2018 | |
| ILMN Illumina | Maintains: Buy | n/a | $105.51 | - | 3 | Jul 31, 2018 |
Ginkgo Bioworks Holdings
Jun 26, 2024
Maintains: Sell
Price Target: $0.5 → $0.2
Current: $0.35
Upside: -42.28%
GeneDx Holdings
Jun 26, 2024
Maintains: Buy
Price Target: $19 → $35
Current: $27.76
Upside: +26.08%
Exact Sciences
Jun 26, 2024
Maintains: Buy
Price Target: $80 → $70
Current: $43.17
Upside: +62.15%
Bionano Genomics
May 16, 2024
Maintains: Buy
Price Target: $3 → $2
Current: $0.57
Upside: +250.75%
Akoya Biosciences
May 14, 2024
Maintains: Buy
Price Target: $9 → $6
Current: $2.18
Upside: +175.23%
Natera
May 13, 2024
Maintains: Buy
Price Target: $100 → $125
Current: $110.70
Upside: +12.92%
NeoGenomics
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $13.73
Upside: +52.95%
Adaptive Biotechnologies
Apr 4, 2024
Maintains: Buy
Price Target: $6 → $5
Current: $3.37
Upside: +48.37%
MaxCyte
Mar 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $3.72
Upside: +115.05%
Alpha Teknova
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.23
Upside: -
MDxHealth
Mar 7, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $2.27
Upside: +252.42%
SOPHiA GENETICS
Mar 6, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $4.59
Upside: +74.29%
Talis Biomedical
Aug 16, 2023
Maintains: Sell
Price Target: $0.35 → $5
Current: $8.50
Upside: -41.18%
Castle Biosciences
Jun 15, 2023
Maintains: Buy
Price Target: $38 → $30
Current: $21.26
Upside: +41.11%
Renalytix
Apr 3, 2023
Maintains: Buy
Price Target: $4 → $3.5
Current: $0.25
Upside: +1,283.95%
Exagen
Mar 22, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $1.78
Upside: +180.90%
CareDx
Feb 28, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $14.90
Upside: +67.79%
Guardant Health
Feb 24, 2023
Maintains: Buy
Price Target: $60 → $50
Current: $28.87
Upside: +73.19%
Cerus
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.70
Upside: -
Lucid Diagnostics
Nov 18, 2022
Maintains: Buy
Price Target: $5 → $3.5
Current: $0.78
Upside: +348.72%
T2 Biosystems
Jul 7, 2022
Downgrades: Neutral
Price Target: n/a
Current: $5.08
Upside: -
OncoCyte
Nov 30, 2020
Initiates: Buy
Price Target: n/a
Current: $2.96
Upside: -
Accelerate Diagnostics
Oct 8, 2020
Initiates: Neutral
Price Target: n/a
Current: $1.15
Upside: -
Labcorp Holdings
Dec 3, 2018
Maintains: Hold
Price Target: n/a
Current: $202.73
Upside: -
Quest Diagnostics
Oct 24, 2018
Maintains: Buy
Price Target: n/a
Current: $136.64
Upside: -
Hologic
Sep 27, 2018
Maintains: Hold
Price Target: n/a
Current: $73.53
Upside: -
QuidelOrtho
Sep 10, 2018
Maintains: Buy
Price Target: n/a
Current: $31.36
Upside: -
Illumina
Jul 31, 2018
Maintains: Buy
Price Target: n/a
Current: $105.51
Upside: -